{
    "id": 17205,
    "cites": 35,
    "cited_by": 3,
    "reference": [
        "Arnould, Richard.. and Larry De Brock. 1996. The Application of Economic Theory to the Vaccine Market. In Supplying Vaccines: An Economic Analysis of Critical Issues. Edited by Mark Pauly, Chester Robinson, Stephen Sepe, Merrile Sing and Mary Kay Williams, Amsterdam: IOS Press.",
        "Aventis Pasteur. 2002. Aventis Pasteur Announces Plans to Meet U.S. Demand for Influenza Vaccine. Press Release, 2 December 2002, www.us.aventispasteur.com.",
        "Bridges, Carolyn B. 2004. General Influenza. Current Issues in Immunization, Net Conference, 8 July 2004, http://www.cdc.gov/nip/ed/ciinc/nc_July_08.htm (15 November 2004).",
        "Carree, Martin and A. Roy Thurik. 1996. Entry and exit in retailing: incentives, barriers, displacement and replacement. Review of Industrial 11: 155-172.",
        "Caves, Richard E.. 1998. Industrial organization and new finding s on turnover and mobility of firms. Journal of Economic Literature 36(4): 1947-1982.",
        "Danzon, Patricia M., Nuno Sousa Pereira and Sapna Tejwani. 2005.Vaccine Supply: A Cross-National Perspective Health Affairs 24(3): 706-717.",
        "DeBrock, Larry M. and Henry Grabowski. 1985. Economic Aspects of Vaccine Innovation and Manufacturing. In Vaccine Supply and Innovation, Institute of Medicine. Washington D.D.: National Academy Press.",
        "Disney, Richard, Jonathan Haskel and Ylda Heden. 2003. Entry, exit and establishment survival in UK manufacturing. The Journal of Industrial Economics 51(1): 91-112.",
        "Timothy Dunne, Mark J. Roberts, and. Larry Samuelson. 1988. Patterns of Firm Entry and Exit in US Manufacturing Industries. RAND Journal of Economics 19(4): 495-515.",
        "Foulkes, Arthur E. 2004. Weakened Immunity: How the Food and Drug Administration Caused Recent Vaccine-Supply Problems. The Lighthouse 9, no. 1 (Summer 2004).",
        "Frankel Glenn. and Glenda Cooper. 2004. Britain: U.S. Told Of Vaccine Shortage: Flu Shot Records Contradict FDA. Washington Post Foreign Service, 9 October 2004, A01.",
        "Geroski, Paul A., Jacquemin, Alexis, Vickers, John, and Venables, Anthony. 1985.  Industrial Change, Barriers to Mobility, and European Industrial Policy. Economic Policy 1 (1): 169-218.",
        "Ghemawat, Pankaj and Barry Nalebuff. 1985. Exit. RAND Journal of Economics 16(2): 184-194.",
        "Ghemawat, Pankaj and Barry Nalebuff. 1990. The Devolution of Declining Industries. Quarterly Journal of Economics 105(1): 167-186.",
        "Grabowski, Henry. 2005. Encouraging The Development Of New Vaccines. Health Affairs 24(3): 697-700 Hosbach, Philip. 2004. Aventis Pasteur Perspective. National Influenza Summit (20-22 May 2003), http://www.ama-assn.org (15 November 2004).",
        "Institute of Medicine. 2003. Financing Vaccines in the 21st Century: Assuring Access and Availability. Washington, DC: IOM.",
        "Jarrett, Steve. 2002. Procurement Strategies for Drugs and Vaccines. Wharton Impact Conference on Pharmaceutical Innovation in a Global Economy. Philadelphia: 4-5 October 2002.",
        "Jovanovic, Boyan, 1992. Selection and the Evolution of Industry. Econometrica, Econometric Society, vol. 50(3): 649-670 Kauf, Teresa L. 1999. Price Discrimination and Bargaining Power in the U.S. Vaccine Market: Implications for Childhood Immunization Policy. Quarterly Review of Economics and Finance 39:249265.",
        "Klepper, Steven. 1996. Entry, exit, growth, and innovation over the product life cycle. American Economic Review 86(3): 562-583.",
        "Klepper, Steven and John H. Miller. 1995. Entry, exit, and shakeouts in the United States in new manufactures products. International Journal of Industrial Organization 12: 567-591.",
        "Lavanchy, Daniel. 2001. WHO Influenza Surveillance. Geneva, Switzerland (5 January 2001).",
        "Manning, Richard L. 1994. Changing Rules in Tort Law and the Market for Childhood Vaccines. Journal of Law and Economics 37(1): 247-75.",
        "Mercer Management Consulting. 2002. Lessons Learned: New Procurement Strategies for Vaccines. Final Report to the GAVI Board. http://www.vaccinealliance.org/Support_to_Country/vpp/index.php.",
        "Nidus Information Services Inc. 2004. What are the Vaccines for Diphtheria, Tetanus, and Pertussis? http://www.nym.org/healthinfo/docs/090/doc90diphtheria.html (15 November 2004).",
        "Orenstein Walter A. 2002. Background/Overview/Meeting Objectives (Conference Presentation).",
        "Offit, Paul A. 2005. The Cutter Incident. New Haven: Yale University Press.",
        "Ruebeck, Christopher S. 2005. Model exit in a vertically differentiated market: interfirm competition versus intrafirm cannibalization in the computer hard disk drive industry. Review of Industrial Organization 26: 27-59.",
        "Salkever, David S. and Richard G. Frank. 1996. Economic Issues in Vaccine Purchase Arrangements. In Supplying Vaccines: An Economic Analysis of Critical Issues. Edited by Mark Pauly, Chester Robinson, Stephen Sepe, Merrile Sing and Mary Kay Williams, Amsterdam: IOS Press.",
        "Scherer, Frederic M. 2007. An Industrial Organization Perspective on the Influenza Vaccine Shortage. Managerial and Decision Economics. 28:393-405.",
        "Thurik, A. Roy and David B. Audretsch. 1996. The Dynamics of Industrial Organization. Review of Industrial Organization 11: 149-153.",
        "Tree, Julia A., Catherine Richardson Anthony R. Fook, J. Christopher Clegga and Denis Loobya. 2001. Comparison of large-scale mammalian cell culture systems with egg culture for the production of influenza virus A vaccine strains. Vaccines 19, no. 25-26 (14 May 2001): 3444-3450.",
        "U.S. Centers for Disease Control and Prevention. 2003. Using Live, Attenuated Influenza Vaccine for Prevention and Control of Influenza: Supplemental Recommendations of the Advisory Committee on Immunization Practices (ACIP). 52(RR13) (26 September 2003): 1-8, http://www.cdc.gov/mmwr/preview/mmwrhtml/Table%201 U.S. Food and Drug Administration, Center for Biologics Evaluation and Research. 2004.",
        "Availability of Influenza Virus Vaccine 1999, http://www.fda.gov/cber/infosheets/flu092999.htm (15 November 2004).",
        "U.S. Government Accounting Office. 2002. Childhood Vaccines: Ensuring and Adequate Supply Poses Continuing Challenges. Washington: GAO.",
        "World Health Organization. 2004. Influenza Vaccine Manufacturers, http://www.who.int/csr/disease/influenza/manulist/en/ (15 November 2004)."
    ]
}